Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RI3W
|
|||
| Drug Name |
1,2,4-triazole [4,3-a]quinoxaline derivative 2
|
|||
| Synonyms |
PMID27321640-Compound-34
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BOEHRINGER INGELHEIM INTERNATIONAL GmbH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H19ClN4O
|
|||
| Canonical SMILES |
CCCCOC1=CC(=C(C=C1)Cl)C2=NN=C3N2C4=CC=CC=C4N=C3C
|
|||
| InChI |
1S/C20H19ClN4O/c1-3-4-11-26-14-9-10-16(21)15(12-14)20-24-23-19-13(2)22-17-7-5-6-8-18(17)25(19)20/h5-10,12H,3-4,11H2,1-2H3
|
|||
| InChIKey |
ITEIGISUTJIFPA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphodiesterase 10A (PDE10) | Target Info | Inhibitor | [1] |
| Phosphodiesterase 2A (PDE2A) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Phosphodiesterase 10A (PDE10) | Target's Patent Info | [1] | |
| Phosphodiesterase 2A (PDE2A) | Target's Patent Info | [1] | ||
| KEGG Pathway | Purine metabolism | |||
| Morphine addiction | ||||
| cGMP-PKG signaling pathway | ||||
| NetPath Pathway | TSH Signaling Pathway | |||
| Pathwhiz Pathway | Purine Metabolism | |||
| Reactome | cGMP effects | |||
| G alpha (s) signalling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2016 Aug;26(8):933-46. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.